Denver Farma S.A. is an Argentine pharmaceutical company founded in 1989, based in Munro, Buenos Aires. It specializes in the production of generic medicines with a broad portfolio of more than 100 products across therapeutic lines including cardiology, diabetology, respiratory, gastroenterology, and hospital supplies. The company is one of the generics market leaders in Argentina and was the first in the country to launch recombinant human insulin (in 2006) through its Denverbio biotechnology plant, which produces human insulin and analogues. Denver Farma manufactures a wide range of pharmaceutical forms such as tablets, capsules, powders, liquids, creams, aerosols, ophthalmic solutions, injectables, and pre-filled syringes, and distributes products both in the national market and internationally across Latin America, the Middle East, and Asia.
| Import | Export |
|---|---|
|
Trade Records
275
|
Trade Records
83
|
|
Suppliers
6
|
Buyers
-
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-06
|
According to Topease's global trade data, DENVER FARMA S A exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
As an importer, DENVER FARMA S A sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore DENVER FARMA S A's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| NEWFARM S.A. | DENVER FARMA S A | 2937 | 24 | $186,500 | 3,420 | Los Angeles |
| INTERQUIM S.A. | DENVER FARMA S A | 2936 | 24 | $186,500 | 3,420 | Los Angeles |
| RECORDATI | DENVER FARMA S A | 2933 | 24 | $186,500 | 3,420 | Los Angeles |
| C.I. FARMACAPSULAS S.A. | DENVER FARMA S A | 9602 | 24 | $186,500 | 3,420 | Los Angeles |
| INTERLIGTH | DENVER FARMA S A | 8539 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into DENVER FARMA S A's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
Chain Insights — Explore DENVER FARMA S A's trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access DENVER FARMA S A's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.